Monte Rosa Therapeutics, Inc. (GLUE) — Analyst estimates
Consensus analyst estimates for Monte Rosa Therapeutics, Inc. — earnings, revenue, and price targets.
| Fiscal Year | Revenue Forecast | EPS Forecast | analysts |
|---|---|---|---|
| 2026 | 13.68M | -0.43 | 1 |
| 2027 | 3.33M | -0.67 | 1 |
| 2028 | 22.25M | -2.29 | 5 |
| 2029 | 115.14M | -2.11 | 1 |
| 2030 | 173.87M | -1.58 | 1 |
Consensus analyst estimates by fiscal year.